Geron Corporation: FDA Approval Fuels Stock Price Surge
Geron(GERN) MarketBeat·2024-06-08 00:57
Geron Today GERN Geron 1.64 ▼ 6.10 Add to Watchlist The recent FDA approval of RYTELO™ (imetelstat) has propelled Geron Corporation NASDAQ: GERN into the spotlight, sparking a surge in Geron’s stock price and attracting heightened attention from investors seeking opportunities within the healthcare sector and biotech sector. This momentous achievement marks a turning point for Geron and underscores the company's commitment to developing innovative the ...